# Exploratory Clinical Study of Personalized mRNA Tumor Vaccine RH125 in Patients With Advanced Solid Tumors

> **NCT07182435** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center** · enrollment: 36 (estimated)

## Conditions studied

- Solid Tumor Malignancies

## Interventions

- **BIOLOGICAL:** personalized neoantigen mRNA tumor vaccine

## Key facts

- **NCT ID:** NCT07182435
- **Lead sponsor:** Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09-15
- **Primary completion:** 2028-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2025-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07182435

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07182435, "Exploratory Clinical Study of Personalized mRNA Tumor Vaccine RH125 in Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT07182435. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*